Commonwealth Equity Services’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-288
| Closed | -$38K | – | 3301 |
|
|
2020
Q3 | $38K | Hold |
288
| – | – | ﹤0.01% | 2976 |
|
|
2020
Q2 | $48K | Hold |
288
| – | – | ﹤0.01% | 2854 |
|
|
2020
Q1 | $41K | Buy |
288
+19
| +7% | +$2.71K | ﹤0.01% | 2704 |
|
|
2019
Q4 | $88K | Buy |
269
+1
| +0.4% | +$327 | ﹤0.01% | 2760 |
|
|
2019
Q3 | $134K | Buy |
268
+8
| +3% | +$4K | ﹤0.01% | 2634 |
|
|
2019
Q2 | $157K | Buy |
260
+60
| +30% | +$36.2K | ﹤0.01% | 2572 |
|
|
2019
Q1 | $122K | Sell |
200
-24
| -11% | -$14.6K | ﹤0.01% | 2574 |
|
|
2018
Q4 | $81K | Buy |
224
+24
| +12% | +$8.68K | ﹤0.01% | 2523 |
|
|
2018
Q3 | $135K | Hold |
200
| – | – | ﹤0.01% | 2597 |
|
|
2018
Q2 | $174K | Hold |
200
| – | – | ﹤0.01% | 2505 |
|
|
2018
Q1 | $251K | Hold |
200
| – | – | ﹤0.01% | 2207 |
|
|
2017
Q4 | $299K | Buy |
200
+93
| +87% | +$139K | ﹤0.01% | 2054 |
|
|
2017
Q3 | $219K | Buy |
107
+56
| +110% | +$115K | ﹤0.01% | 2205 |
|
|
2017
Q2 | $134K | Hold |
51
| – | – | ﹤0.01% | 2334 |
|
|
2017
Q1 | $153K | Hold |
51
| – | – | ﹤0.01% | 2221 |
|
|
2016
Q4 | $76K | Buy |
+51
| New | +$76K | ﹤0.01% | 2219 |
|